The crosstalk between PFKFB3 and RSPO2 drives sepsis-induced lung injury by coupling metabolic rewiring to macrophage inflammation
Translational Research · 2026
DOI: 10.1016/j.trsl.2026.08.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Research, 2026. Verfasst von Yao Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. Hauptthemen laut MEDLINE: Phosphofructokinase-2, Sepsis, Macrophages, Inflammation. Die Arbeit nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Themen: Sepsis
Abstract (Originalsprache)
Aberrantly activated macrophages drive acute lung injury (ALI), but how metabolic reprogramming fuels their dysfunction remains elusive. Here, we investigated PFKFB3, a glycolytic enzyme converting fructose-6-phosphate to fructose-2,6-bisphosphate, in ALI. PFKFB3 was upregulated both in LPS-stimulated macrophages and septic mice, cascading RSPO2 activation. Pharmacological inhibition of PFKFB3 by PFK15 not only mitigated LPS-induced macrophage injury via NF-κB suppression but also protected against ALI in CLP mice. PFK15 effectively blunted PFKFB3-dependent glycolysis and curtailed pro-inflammatory responses by inhibiting RSPO2/β-catenin signaling both in vitro and in vivo. Genetic silencing of PFKFB3 similarly reduced inflammation and suppressed RSPO2/β-catenin signaling. Notably, RSPO2 knockdown ameliorated LPS-induced macrophage dysfunction characterized by hyperglycolysis and excessive inflammation. This protective effect was phenocopied by KYA1797K, an RSPO2/β-catenin inhibitor, which reduced macrophage inflammation and glycolytic activity, thereby alleviating ALI. Collectively, our data support a model wherein a positive feedback loop interconnecting PFKFB3-driven glycolysis and RSPO2 signaling synergizes with the NF-κB pathway to potentiate macrophage inflammation, ultimately exacerbating septic ALI. These findings establish the PFKFB3-RSPO2 circuit as a promising therapeutic target for ALI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
- Department of Anesthesiology, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
- Department of Orthopedic Surgery, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
- Department of Anesthesiology, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. Electronic address: 2025030062@usc.edu.cn.
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Wang, Y., Zeng, J., Dai, X., Peng, R., & Wang, D. (2026). The crosstalk between PFKFB3 and RSPO2 drives sepsis-induced lung injury by coupling metabolic rewiring to macrophage inflammation. Translational Research. https://doi.org/10.1016/j.trsl.2026.08.009
Vancouver
Wang Y, Zeng J, Dai X, Peng R, Wang D. The crosstalk between PFKFB3 and RSPO2 drives sepsis-induced lung injury by coupling metabolic rewiring to macrophage inflammation. Translational Research. 2026. doi:10.1016/j.trsl.2026.08.009
BibTeX
@article{Wang2026,
author = {Wang, Yao and Zeng, Juan and Dai, Xiang and Peng, Rui and Wang, Dan},
title = {The crosstalk between PFKFB3 and RSPO2 drives sepsis-induced lung injury by coupling metabolic rewiring to macrophage inflammation},
journal = {Translational Research},
year = {2026},
doi = {10.1016/j.trsl.2026.08.009}
}
EUVIMED